Marianna Foldvari, DPharmSci, PhD
Canada Research Chair in Bionanotechnology and Nanomedicine
Professor of Pharmaceutical Sciences
School of Pharmacy, University of Waterloo
| Education |
PhD, Pharmaceutical Sciences Halifax, Nova Scotia D Pharm Sci, Doctorate in Pharmaceutical Sciences Summa cum laude Faculty of Pharmacy Budapest, Hungary BSc, Faculty of Pharmacy Budapest, Hungary |
| Distinctions |
Award of Innovation, University of Saskatchewan and Innovation Place, 2005 Listing in A. Wood, Canadian Women Invent!, 2001 Helix Chair in Industrial Pharmacy, University of Saskatchewan, 1996–1999 YWCA Women of Distinction Award Recipient (Entrepreneur/Innovator Category), 1997 |
| Research support |
Design and development of targeted gene delivery systems Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine: Innovative Approaches in Health Research Team Grant Program Micro- and nanoscale delivery systems for macromolecules Transdermal delivery systems for protein medicines and vaccines Cutaneous gene therapy for localized scleroderma: Development of novel delivery systems for the interferon gamma gene |
| Editorial activities |
Nanomedicine: Nanotechnology, Biology and Medicine - Associate Editor Current Drug Delivery - Hot Topic Editor Recent Patents on Nanomedicine - Editorial board International Journal of Pharmaceutical Compounding - Editorial board Journal of Nanomedicine & Biotherapeutic Discoveries - Editorial board Journal of Bionanoscience - Editorial board |
| Memberships |
American Association for the Advancement of Science |
| Collaborators |
Prof. Jonathan Hadgraft — Department of Pharmaceutics, University of London Dr. Ronald Verrall — Department of Chemistry, University of Saskatchewan Dr. Alan Rosenberg — Department of Pediatrics, Royal University Hospital, Saskatoon Dr. Peter Hull — Department of Dermatology, Royal University Hospital, Saskatoon Dr. Lorne Babiuk — Vaccine and Infectious Disease Organization |
Research Entrepreneurship |
Dr. Foldvari founded two spin-off companies that have commercialized drug delivery technologies she and her research group have developed. PharmaDerm Laboratories Ltd. Founded in 1991 Merged with Helix BioPharma Inc. in 1999 Company mandate: To develop topical products based on the Biphasix™ technology |
Forte Pharmaceuticals Inc. — Founded in 2002 Company mandate: R&D in nanotechnology |
School of Pharmacy
10 Victoria St. S
Kitchener, Ontario, Canada N2G 1C5
Phone: (519) 888-4499
Fax: (519) 888-7910
Contact Us | http://www.pharmacy.uwaterloo.ca |
